<VariationArchive VariationID="846457" VariationName="NM_001453.3(FOXC1):c.451dup (p.Tyr151fs)" VariationType="Duplication" Accession="VCV000846457" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="831738" VariationID="846457">
      <GeneList>
        <Gene Symbol="FOXC1" FullName="forkhead box C1" GeneID="2296" HGNC_ID="HGNC:3800" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="1609915" stop="1613897" display_start="1609915" display_stop="1613897" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="1610680" stop="1614131" display_start="1610680" display_stop="1614131" Strand="+" />
          </Location>
          <OMIM>601090</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001453.3(FOXC1):c.451dup (p.Tyr151fs)</Name>
      <CanonicalSPDI>NC_000006.12:1610895:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="1610895" stop="1610896" display_start="1610895" display_stop="1610896" variantLength="1" positionVCF="1610895" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="1611130" stop="1611131" display_start="1611130" display_stop="1611131" variantLength="1" positionVCF="1611130" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>Y151fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.1610896dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.1610896dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009368.1" sequenceAccession="NG_009368" sequenceVersion="1" change="g.5451dup">
            <Expression>NG_009368.1:g.5451dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001453.3" sequenceAccession="NM_001453" sequenceVersion="3" change="c.451dup" MANESelect="true">
            <Expression>NM_001453.3:c.451dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001444.2" sequenceAccession="NP_001444" sequenceVersion="2" change="p.Tyr151fs">
            <Expression>NP_001444.2:p.Tyr151fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.1611131dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.1611131dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1245" sequenceAccession="LRG_1245">
            <Expression>LRG_1245:g.5451dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1245t1" sequenceAccession="LRG_1245t1">
            <Expression>LRG_1245t1:c.451dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1245p1" sequenceAccession="LRG_1245p1" change="p.Tyr151fs">
            <Expression>LRG_1245p1:p.Tyr151fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1762525473" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001453.3(FOXC1):c.451dup (p.Tyr151fs) AND Axenfeld-Rieger syndrome type 3" Accession="RCV001049764" Version="7">
        <ClassifiedConditionList TraitSetID="2331">
          <ClassifiedCondition DB="MedGen" ID="C2678503">Axenfeld-Rieger syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-11-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16638984</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20881294</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2331" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="371" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Axenfeld-Rieger syndrome type 3</ElementValue>
                <XRef ID="Axenfeld+Rieger+Syndrome+Type+3/694" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011233" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Axenfeld-rieger anomaly with or without cardiac defects and/or sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rieger syndrome type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anterior chamber cleavage syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AXENFELD-RIEGER ANOMALY WITH CARDIAC DEFECTS AND/OR SENSORINEURAL HEARING LOSS</ElementValue>
                <XRef Type="MIM" ID="602482" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RIEG3</ElementValue>
                <XRef Type="MIM" ID="602482" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9626" />
                <XRef ID="9626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="pmc">3061995</ID>
              </Citation>
              <XRef ID="782" DB="Orphanet" />
              <XRef ID="C2678503" DB="MedGen" />
              <XRef ID="MONDO:0011233" DB="MONDO" />
              <XRef Type="MIM" ID="602482" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2379204" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8795705|MedGen:C2678503" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001213834" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16638984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20881294</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the FOXC1 protein. Other variant(s) that disrupt this region (p.Leu240Valfs*65 and p.Ser272Argfs*43) have been determined to be pathogenic (PMID: 16638984, 20881294, Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with FOXC1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the FOXC1 gene (p.Tyr151Leufs*155). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 403 amino acids of the FOXC1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.1611130_1611131insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2678503" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2379204" TraitType="Disease" MappingType="XRef" MappingValue="C2678503" MappingRef="MedGen">
        <MedGen CUI="C2678503" Name="Axenfeld-Rieger syndrome type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

